Targeted interleukin 8 (IL-8 or CXCL8) for treating endometriosis

Szu-Ting Yang, Yang ST, Szu‐Ting Yang, Chang WH, Wen-Hsun Chang, Huang HY, Hong‐Yuan Huang, Hong-Yuan Huang, Peng‐Hui Wang, Wang PH, Peng-Hui Wang
Taiwanese journal of obstetrics & gynecology · 2026 · vol. 65(5) , pp. 885–887 · doi:10.1016/j.tjog.2026.06.002 · PMID:42642142 · W7204207422
Other OA: diamond public-domain-us
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

This paper explores the potential of targeting interleukin 8 (IL-8 or CXCL8) as a therapeutic strategy for treating endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (16)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-10-14T06:01:35.214979+00:00
pubmed
last seen: 2026-10-14T06:03:15.063680+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine